InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: Serenity3 post# 12978

Thursday, 03/01/2018 2:40:04 PM

Thursday, March 01, 2018 2:40:04 PM

Post# of 16885
FDA to expand MAT for Opioid Addicts
https://www.nytimes.com/2018/02/25/science/fda-medication-assisted-therapy.html
"Noting federal data showing that only one-third of specialty substance abuse treatment programs offer medication-assisted treatment, Mr. Azar said, “We want to raise that number — in fact, it will be nigh impossible to turn the tide on this epidemic without doing so.”

"The F.D.A. has approved three drugs for opioid treatment — buprenorphine (often known by the brand name Suboxone), methadone and naltrexone (known by the brand name Vivitrol) — and says they are safe and effective combined with counseling and other support. But the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

One encourages the development of new, longer-acting formulations of existing drugs for opioid treatment. The other, which was described in detail to The Times, said new drugs would be eligible for approval that don’t end addiction but help with aspects of it, such as cravings, or overdoses, with the goal remaining complete abstinence." “We will permit an endpoint that shows substantial reductions but does not require the patient to be totally clean at every visit if the measurements are fairly frequent,” a senior F.D.A. official said."

details to be released in March .. certainly lack of access will become a legal issue as measured by the "standard of care".. hence hereto mentioned lawsuits against insurance companies that deny access by claiming no medical necessity.. try establishing in court that you are not practicing contrary to the "standard of care" for someone who has died
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News